Share Helix Biopharma Corp. Extends LEUMUNA Option With metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases Feb. 5, 2026 4:30 PM ET Source: Helix BioPharma Corp. Stock Quote More Company News Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London Helix BioPharma Corp. Announces Voting Results From Its Annual General and Special Meeting Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025
Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025
